Updates are available Erratum dated 2023-01-01
Click to view Erratum: https://doi.org/10.1186/s13613-023-01193-y
-
Authors
Cholley, Bernard https://orcid.org/0000-0001-6388-6011
Bojan, Mirela
Guillon, Benoit
Besnier, Emmanuel
Mattei, Mathieu
Levy, Bruno
Ouattara, Alexandre
Tafer, Nadir
Delmas, Clément
Tonon, David
Rozec, Bertrand
Fellahi, Jean-Luc
Lim, Pascal
Labaste, François
Roubille, François
Caruba, Thibaut
Mauriat, Philippe
Barbot, Olivier
Laurent, Berthomieu
Besselat, Anne-Marie
Katrien, Blanchart
Bougle, Adrien
Bourgoin, Pierre
Arnaud, Causeret
Charbonneau, Hélène
Cristinar, Mircea
Desebbe, Olivier
Eljezi, Veldat
Genet, Thibaud
Grenier, Maxime
Guinot, Pierre Grégoire
Lebel, Stéphane
Levy, Yael
Lion, François
Mansourati, Jacques
Marlière, Stéphanie
Martin, Anne-Céline
Mebazaa, Alexandre
Mohammad, Usman
Monsegu, Jacques
Nessler, Nicolas
Orsel, Isabelle
Puymirat, Etienne
Recher, Morgan
Soussi, Sabri
Troussard, Vincent
Uhry, Sabrina
Zirphile, Xavier
-
Funding
Funding for this research was provided by:
Orionin Tutkimussäätiö
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Overview of the current use of levosimendan in France: a prospective observational cohort study
Journal Title: Annals of Intensive Care
CrossRef DOI link to publisher maintained version: https://doi.org/10.1186/s13613-023-01164-3
Content Type: article
Copyright: Copyright © 2023 The Author(s) 2023. Published by Elsevier Masson SAS
